Ebsteins anomaly of the tricuspid valve risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Administration of [[Lithium]] Carbonate or [[benzodiazepines]] during pregnancy is associated with a higher risk of Ebstein's anomaly. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| Line 22: | Line 18: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Congenital heart disease]] | |||
Revision as of 01:56, 20 October 2012
|
Ebsteins anomaly of the tricuspid valve Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Ebsteins anomaly of the tricuspid valve risk factors On the Web | |
|
American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve risk factors | |
|
Ebsteins anomaly of the tricuspid valve risk factors in the news | |
|
Blogs on Ebsteins anomaly of the tricuspid valve risk factors | |
|
Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve risk factors | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Overview
Administration of Lithium Carbonate or benzodiazepines during pregnancy is associated with a higher risk of Ebstein's anomaly.